DECEMBER, 2013 Gene-Related Patents Issued - Full patent: http://patft.uspto.gov/netahtml/PTO/srchnum.htm |
CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY |
Pat No |
Title |
Assignee |
Date Issued |
Country |
8,603,795 |
Fungal protease and use thereof |
AB Enzymes Oy |
10-Dec-13 |
Finland |
8,609,390 |
Fungal serine protease and use thereof |
AB Enzymes Oy |
17-Dec-13 |
Finland |
8,614,085 |
Yeast with increased butanol tolerance involving a multidrug efflux pump gene |
Butamax(TM) Advanced Biofuels LLC |
24-Dec-13 |
United States |
8,603,996 |
Modular aptamer-regulated ribozymes |
California Institute of Technology |
10-Dec-13 |
United States |
8,609,335 |
Self-assembled single molecule arrays and uses thereof |
Callida Genomics, Inc. |
17-Dec-13 |
United States |
8,614,058 |
Molecular prognostic signature for predicting breast cancer metastasis, and uses thereof |
Celera Corporation |
24-Dec-13 |
United States |
8,597,910 |
DNA encoding Von Willebrand Factor (VWF) and methods and cells for producing VFW, and VFW produced by the DNA, methods and cells |
Children's Medical Center Corporation |
3-Dec-13 |
United States |
8,609,396 |
Microorganism producing O-acetyl-homoserine and the method of producing O-acetyl-homoserine using the microorganism |
CJ Cheiljedang Corporation |
17-Dec-13 |
Korea |
8,603,797 |
Methods and compositions for targeted mutagenesis in bacteria |
Cornell University |
10-Dec-13 |
United States |
8,609,369 |
Yarrowia peroxisomal 2,4-dienoyl-CoA reductase promoter regions for gene expression in yeast |
E I du Pont de Nemours and Company |
17-Dec-13 |
United States |
8,609,405 |
GABA neuron progenitor cell marker 65B13 |
Eisai R&D Management Co., Ltd. |
17-Dec-13 |
Japan |
8,597,918 |
Process of separating components of a fermentation broth |
Genomatica, Inc. |
3-Dec-13 |
United States |
8,609,394 |
Biotechnological production of chondroitin |
Gnosis S.p.A. |
17-Dec-13 |
Italy |
8,597,942 |
System for expression of genes in plants |
iBio, Inc. |
3-Dec-13 |
United States |
8,617,845 |
Sequence diversity generation in immunoglobulins |
Innovative Targeting Solutions, Inc. |
31-Dec-13 |
Canada |
8,597,931 |
Mutant yeast strains capable of accumulating a large quantity of lipids |
Institut National de la Recherche Agronomique |
3-Dec-13 |
France |
8,603,798 |
Process for large scale production of plasmid DNA by E. coli fermentation |
Merck Sharp & Dohme Corp. |
10-Dec-13 |
United States |
8,617,875 |
Expression vector suitable for expression of a coding sequence for gene therapy |
Mogam Biotechnology Research Institute |
31-Dec-13 |
Korea |
8,603,774 |
Extract of E. coli cells having mutation in ribosomal protein S12, and method for producing protein in cell-free system using the extract |
National Food Research Institute |
10-Dec-13 |
Japan |
8,609,342 |
Reporter gene assay method |
Otsuka Pharmaceutical Co., Ltd. |
17-Dec-13 |
Japan |
8,603,824 |
Process for improved protein expression by strain engineering |
Pfenex, Inc. |
10-Dec-13 |
United States |
8,603,814 |
Method of inhibiting nonsense-mediated mRNA decay |
Rutgers the State University of New Jersey |
10-Dec-13 |
United States |
8,597,877 |
Polymorphic loci that differentiate Escherichia coli O157:H7 from other strains |
Seattle Children's Hospital |
3-Dec-13 |
United States |
8,597,923 |
Oxidation of compounds using genetically modified Candida |
SyntheZyme, LLC |
3-Dec-13 |
United States |
8,597,880 |
Methods and compositions for identifying increased risk of developing fragile X-associated disorders |
The Fred Hutchinson Cancer Research Center |
3-Dec-13 |
United States |
8,617,876 |
Rhodopsin gene conserved regions in a viral vector enhance expression |
The Provost Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth |
31-Dec-13 |
Ireland |
8,614,094 |
Compositions and methods for determining genetic polymorphisms in the TMEM216 gene |
The Regents of the University of California |
24-Dec-13 |
United States |
8,617,815 |
Molecules with effects on cellular development and function |
The Regents of the University of California |
31-Dec-13 |
United States |
8,617,813 |
Methods for modulating embryonic stem cell differentiation |
The United States of America as represented by the Secretary of the Department of Health and Human Services |
31-Dec-13 |
United States |
8,617,812 |
Polymorphism in bovine prion protein gene sequence |
The United States of America, as represented by the Secretary of Agriculture |
31-Dec-13 |
United States |
8,603,748 |
Genetic methods for speciating Campylobacter |
The United States of America, as represented by the Secretary of Agriculture |
10-Dec-13 |
United States |
8,597,883 |
Biomarkers for cancer-related fatigue and use thereof |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
3-Dec-13 |
United States |
8,597,885 |
Accelerated progression relapse test |
University of Notre Dame |
3-Dec-13 |
United States |
8,614,060 |
Methods and compositions for predicting drug responses |
University of Washington |
24-Dec-13 |
United States |
8,597,893 |
Human phospholipase A2 epsilon |
Washington University In St. Louis |
3-Dec-13 |
United States |
|
COMBINATORIAL CHEMISTRY TECHNOLOGY |
Pat No |
Title |
Assignee |
Date Issued |
Country |
8,598,080 |
Rice cultivar designated `CL131` |
Board of Supervisors of Louisiana State University And Agricultural and Mechanical College |
3-Dec-13 |
United States |
|
DRUG |
Pat No |
Title |
Assignee |
Date Issued |
Country |
8,598,136 |
Baculovirus-mediated transgene expression in both mammalian and insect cells |
Academia Sinica |
3-Dec-13 |
Taiwan |
8,598,139 |
Lipid formulated dsRNA targeting the PCSK9 gene |
Alnylam Pharmaceuticals, Inc. |
3-Dec-13 |
United States |
RE44,681 |
Compositions and methods for inhibiting growth of SMAD4-deficient cancers |
Biogen Idec MA Inc. |
31-Dec-13 |
United States |
8,609,626 |
NLK as a marker for diagnosis of liver cancer and as a therapeutic agent thereof |
Catholic University Industry Academic Cooperation Foundation |
17-Dec-13 |
Korea |
8,603,997 |
siRNA that inhibits WT1 gene expression and uses thereof |
Haruo Sugiyama |
10-Dec-13 |
Japan |
8,603,480 |
Human cytomegalovirus neutralizing antibodies and use thereof |
Institute for Research in Biomedicine |
10-Dec-13 |
United States |
8,598,188 |
Method for predicting therapeutic efficacy of chemotherapy on non-small-cell lung cancer |
Kinki University |
3-Dec-13 |
United States |
8,609,065 |
Molecules for targeting compounds to various selected organs, tissues or tumor cells |
Kuik-Romeijn; Petra Van |
17-Dec-13 |
Netherlands |
8,618,070 |
Anti-sense oligonucleotides targeted against exon 9 of IL-23R.alpha. gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases |
Medical Diagnostic Laboratories, LLC |
31-Dec-13 |
United States |
8,603,465 |
Methods for treatment of polyposis |
Merck Sharp & Dohme, Corp. |
10-Dec-13 |
United States |
8,603,995 |
dsRNA for treating viral infection |
Novartis AG |
10-Dec-13 |
Switzerland |
8,598,133 |
Methods for treating pain |
The Regents of the University of Colorado |
3-Dec-13 |
United States |
8,609,108 |
Gamma-glutamyl transpeptidase attenuated Francisella |
The Secretary of State for Defence |
17-Dec-13 |
United Kingdom |
8,603,459 |
Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
The Trustees of the University of Pennsylvania |
10-Dec-13 |
United States |
8,598,143 |
Sequence-specific inhibition of small RNA function |
University of Massachusetts |
3-Dec-13 |
United States |
8,603,994 |
Transcriptional repression leading to Parkinson's disease |
Valted, LLC |
10-Dec-13 |
United States |
8,597,637 |
Breast cancer therapy using an engineered respiratory syncytial virus |
Zhang; Weidong |
3-Dec-13 |
United States |
|
MULTICELLULAR LIVING ORGANISMS |
Pat No |
Title |
Assignee |
Date Issued |
Country |
8,598,412 |
Seed specific USP promoters for expressing genes in plants |
Dow AgroSciecnes, LLC. |
3-Dec-13 |
United States |
8,598,413 |
AAD-1 event DAS-40278-9, related transgenic corn lines, event-specific identification thereof, and methods of weed control involving AAD-1 |
Dow AgroSciecnes, LLC. |
3-Dec-13 |
United States |
8,598,409 |
Non-human organism comprising a gene expression modulation system encoding a chimeric retinoid X receptor |
Intrexon Corporation |
3-Dec-13 |
United States |
8,604,275 |
Constitutive translationally controlled tumor protein (TCTP) promoter from oil palm type 2 |
Malaysian Palm Oil Board |
10-Dec-13 |
Malaysia |
8,614,370 |
Nucleic acid sequences from Diabrotica virgifera virgifera leconte and uses thereof |
Monsanto Technology LLC |
24-Dec-13 |
United States |
8,609,934 |
In vivo assembly of transcription units |
Monsanto Technology LLC |
17-Dec-13 |
United States |
8,604,276 |
Switchgrass ubiquitin promoter (PVUBI2) and uses thereof |
University of Tennessee Research Foundation |
10-Dec-13 |
United States |
8,609,928 |
Squash leaf curl virus (SLCV) resistance in cucurbits |
Vilmorin & Cie |
17-Dec-13 |
France |
|
NATURAL RESINS OR DERIVATIVES |
Pat No |
Title |
Assignee |
Date Issued |
Country |
8,604,169 |
Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer |
Agensys, Inc. |
10-Dec-13 |
United States |
8,609,819 |
Extracellular serine protease |
Board of Trutees of the University of Arkansas |
17-Dec-13 |
United States |
8,604,173 |
Dopaminergic neuron progenitor cell marker 187A5 |
Eisai R&D Management Co., Ltd. |
10-Dec-13 |
Japan |
|
ORGANIC COMPOUNDS |
Pat No |
Title |
Assignee |
Date Issued |
Country |
8,598,333 |
SiRNA silencing of genes expressed in cancer |
Alnylam Pharmaceuticals, Inc. |
3-Dec-13 |
United States |
8,604,176 |
Protein-responsive RNA control devices and uses thereof |
California Institute of Technology |
10-Dec-13 |
United States |
8,598,330 |
CC2D2A gene mutations associated with joubert syndrome and diagnostic methods for identifying the same |
Centre for Addiction and Mental Health |
3-Dec-13 |
Canada |
8,604,183 |
Compositions comprising alternating 2'-modified nucleosides for use in gene modulation |
Isis Pharmaceuticals, Inc. |
10-Dec-13 |
United States |
8,618,273 |
Partial fragment of REIC/Dkk-3 gene and cancer therapeutic agent comprising the same |
Kumon; Hiromi |
31-Dec-13 |
Japan |
8,609,830 |
Methods and compositions for RNA interference |
Merck Sharp & Dohme Corp. |
17-Dec-13 |
United States |
8,618,277 |
RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
Merck Sharp & Dohme Corp. |
31-Dec-13 |
United States |
8,598,328 |
Tol1 factor transposase and DNA introduction system using the same |
National University Corporation Nagoya University |
3-Dec-13 |
Japan |
8,604,180 |
DNA fragment having promoter function |
Research Institute of Innovative Technology for the Earth |
10-Dec-13 |
Japan |
|
ORGANIC COMPOUNDS |
Pat No |
Title |
Assignee |
Date Issued |
Country |
8,618,304 |
Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals |
Sanofi |
31-Dec-13 |
France |
8,614,305 |
Nonviral gene delivery vector iopamidol, protamine, ethiodized oil reagent (VIPER) |
The Board of Trustees of the Leland Stanford Junior University |
24-Dec-13 |
United States |
8,604,179 |
Nucleic acid comprising chimeric gene derived from hepatitis C virus |
Toray Industries, Inc. |
10-Dec-13 |
Japan |
8,609,831 |
RNA-mediated gene modulation |
University of Southern California |
17-Dec-13 |
United States |
|
PLANT PROTECTING AND REGULATING COMPOSITIONS |
Pat No |
Title |
Assignee |
Date Issued |
Country |
8,597,913 |
Method of constructing an expression cassette comprising regulatory sequences of a target gene of a plant for expressing gene products |
Syngenta Participations AG |
3-Dec-13 |
Switzerland |
|
SURGERY |
Pat No |
Title |
Assignee |
Date Issued |
Country |
8,620,423 |
Methods for thermal modulation of nerves contributing to renal function |
Medtronic Ardian Luxembourg S.a.r.l. |
31-Dec-13 |
Luxembourg |